As I just explained and explained previously, they do not have to do that. Once approved, extending such a drug will be much easier than ever before. The mere act of approval is going to set this up for a mushrooming impact in oncology. There is nothing that the anti-dc cancer vaccine crowd can do about it.
Market Data 
Markets 
AI
